ResearcherChinese PLA General HospitalNo recent work listed
Zhiming Zhao
Matched on ORCID iD 0000-0003-3131-2843; OpenAlex author ID A5114444539. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 7
- DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer. Co-author DOI 10.1186/s12885-023-11524-8↗
- Retraction Note to: Linc‑ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR‑124/PTBP1/PKM2 axis. First author DOI 10.1007/s00280-021-04364-5↗
- MicroRNA-4656 is a prognostic factor and tumor suppressor in human pancreatic cancer through a downstream target of TrkA. Co-author DOI 10.1002/jgm.2938↗
- Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis. First author DOI 10.1007/s00280-016-3178-4↗
- PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/s10620-015-3931-2↗
- Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Co-author DOI 10.3892/mmr.2015.4060↗
- Comment on Han L et al.: prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. First author DOI 10.1007/s13277-014-2507-7↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rong Liu · 5 shared papers, 2014–2023 · strength 0.67
- Paper Retraction Note to: Linc‑ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modul… DOI 10.1007/s00280-021-04364-5↗
- Paper DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in panc… DOI 10.1186/s12885-023-11524-8↗
- Paper Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PT… DOI 10.1007/s00280-016-3178-4↗
- Chenggang Li · 4 shared papers, 2015–2022 · strength 0.45
- Paper Retraction Note to: Linc‑ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modul… DOI 10.1007/s00280-021-04364-5↗
- Paper Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PT… DOI 10.1007/s00280-016-3178-4↗
- Paper MicroRNA-4656 is a prognostic factor and tumor suppressor in human pancreatic cancer through a downstream target of Trk… DOI 10.1002/jgm.2938↗
- Zhaoda Deng · 1 shared paper, 2023 · strength 0.20
- Lincheng Li · 1 shared paper, 2023 · strength 0.20
- Fei Wang · 1 shared paper, 2023 · strength 0.20
- Chenggang Li · 2 shared papers, 2014–2016 · strength 0.16
- Paper PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenoc… DOI 10.1007/s10620-015-3931-2↗
- Paper Comment on Han L et al.: prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysi… DOI 10.1007/s13277-014-2507-7↗
- Minggen Hu · 1 shared paper, 2017 · strength 0.08
- Tan X · 1 shared paper, 2017 · strength 0.08
- Dabin Xu · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.